Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2003 1
2005 1
2006 1
2008 3
2009 4
2010 1
2014 1
2015 1
2016 2
2018 1
2020 1
2021 5
2022 7
2023 11
2024 17
2025 19
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Barriers to Chimeric Antigen Receptor T-Cell Therapy.
Valtis YK, Chin KK, Nemirovsky D, Devlin SM, Yisraeli Salman M, Boussi L, Cadzin B, McLoughlin C, Cathcart E, Davis P, Brooklyn C, Goldstein T, Famulare C, Shah GL, Walji M, Scordo M, Boardman AP, Shouval R, Stein EM, Geyer MB, Mailankody S, Palomba ML, Usmani SZ, Salles G, Giralt SA, Perales MA, Park JH. Valtis YK, et al. Among authors: nemirovsky d. JAMA Oncol. 2025 Jul 1;11(7):781-784. doi: 10.1001/jamaoncol.2025.1127. JAMA Oncol. 2025. PMID: 40372728
Organ preservation after neoadjuvant long-course chemoradiotherapy versus short-course radiotherapy.
Bercz A, Park BK, Pappou E, Nemirovsky D, Sarkar R, Yamner M, Omer D, Verheij FS, Alvarez J, Atri P, Reyngold M, Yaeger R, Wei IH, Wu A, Raj N, Widmar M, Hajj C, Kim MJ, Rao D, Nash GM, Williams V, Shia J, Segal NH, Diaz L, Ganesh K, Weiser MR, Gollub MJ, Paty PB, Horvat N, Zinovoy M, Roth O'Brien D, Sanchez-Vega F, Saltz LB, Crane CH, Cercek A, Gonen M, Garcia-Aguilar J, Smith JJ, Romesser PB. Bercz A, et al. Among authors: nemirovsky d. Ann Oncol. 2024 Nov;35(11):1003-1014. doi: 10.1016/j.annonc.2024.07.729. Epub 2024 Sep 11. Ann Oncol. 2024. PMID: 39266364 Free PMC article.
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma.
Nath K, Shekarkhand T, Nemirovsky D, Derkach A, Costa BA, Nishimura N, Farzana T, Rueda C, Chung DJ, Landau HJ, Lahoud OB, Scordo M, Shah GL, Hassoun H, Maclachlan K, Korde N, Shah UA, Tan CR, Hultcrantz M, Giralt SA, Usmani SZ, Shahid Z, Mailankody S, Lesokhin AM. Nath K, et al. Among authors: nemirovsky d. Blood Cancer J. 2024 May 31;14(1):88. doi: 10.1038/s41408-024-01043-5. Blood Cancer J. 2024. PMID: 38821925 Free PMC article.
Belantamab mafodotin in patients with relapsed/refractory multiple myeloma: a real-world experience.
Hultcrantz M, Derkach A, Hassoun H, Korde N, Maclachlan K, Mailankody S, Patel D, Shah UA, Tan CR, Chung DJ, Lahoud OB, Landau HJ, Scordo M, Shah GL, Nemirovsky D, Firestone RS, Akhlaghi T, Shekarkhand T, Giralt SA, Lesokhin AM, Usmani SZ. Hultcrantz M, et al. Among authors: nemirovsky d. Blood Neoplasia. 2025 Apr 16;2(3):100103. doi: 10.1016/j.bneo.2025.100103. eCollection 2025 Aug. Blood Neoplasia. 2025. PMID: 40575079 Free PMC article.
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Olde Nordkamp LRA, Pepplinkhuizen S, Ghani A, Boersma LVA, Kuschyk J, El-Chami MF, Behr ER, Brouwer TF, Kääb S, Mittal S, Quast ABE, van der Stuijt W, Smeding L, de Veld JA, Tijssen JGP, Bijsterveld NR, Richter S, Brouwer MA, de Groot JR, Kooiman KM, Lambiase PD, Neuzil P, Vernooy K, Alings M, Betts TR, Bracke FALE, Burke MC, de Jong JSSG, Wright DJ, Jansen WPJ, Whinnett ZI, Nordbeck P, Knaut M, Philbert BT, van Opstal JM, Chicos AB, Allaart CP, Borger van der Burg AE, Dizon JM, Miller MA, Nemirovsky D, Surber R, Upadhyay GA, Weiss R, de Weger A, Wilde AAM, Knops RE; PRAETORIAN Investigators. Olde Nordkamp LRA, et al. Among authors: nemirovsky d. Circ Arrhythm Electrophysiol. 2024 Dec;17(12):e012836. doi: 10.1161/CIRCEP.124.012836. Epub 2024 Dec 3. Circ Arrhythm Electrophysiol. 2024. PMID: 39624908 Clinical Trial.
Subcutaneous or Transvenous Defibrillator Therapy.
Knops RE, Olde Nordkamp LRA, Delnoy PHM, Boersma LVA, Kuschyk J, El-Chami MF, Bonnemeier H, Behr ER, Brouwer TF, Kääb S, Mittal S, Quast ABE, Smeding L, van der Stuijt W, de Weger A, de Wilde KC, Bijsterveld NR, Richter S, Brouwer MA, de Groot JR, Kooiman KM, Lambiase PD, Neuzil P, Vernooy K, Alings M, Betts TR, Bracke FALE, Burke MC, de Jong JSSG, Wright DJ, Tijssen JGP, Wilde AAM; PRAETORIAN Investigators. Knops RE, et al. N Engl J Med. 2020 Aug 6;383(6):526-536. doi: 10.1056/NEJMoa1915932. N Engl J Med. 2020. PMID: 32757521 Clinical Trial.
Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma.
Adegbite B, Tan CR, Shekarkhand T, Firestone RS, Jurgens EM, Miller K, Lesokhin AM, Shah GL, Korde N, Rajeeve S, Landau HJ, Scordo M, Hassoun H, Maclachlan KH, Shah UA, Hultcrantz M, Hamadeh IS, Derkach A, Nemirovsky D, Giralt SA, Mailankody S, Usmani SZ, Hashmi H. Adegbite B, et al. Among authors: nemirovsky d. Blood Adv. 2025 Aug 12;9(15):4016-4022. doi: 10.1182/bloodadvances.2025015973. Blood Adv. 2025. PMID: 40315372 Free PMC article.
Restarting teclistamab and talquetamab after prolonged dose delay may not require re-step-up dosing.
Tan CR, Wang A, Nemirovsky D, Derkach A, Shekarkhand T, Hamadeh I, Maclachlan K, Hultcrantz M, Hassoun H, Mailankody S, Lesokhin A, Shah UA, Rajeeve S, Hashmi H, Patel D, Firestone R, Jurgens E, Miller K, Shah GL, Scordo M, Landau HJ, Giralt SA, Korde N, Usmani SZ. Tan CR, et al. Among authors: nemirovsky d. Blood Adv. 2025 Jul 8;9(13):3331-3335. doi: 10.1182/bloodadvances.2024015344. Blood Adv. 2025. PMID: 40048741 Free PMC article. No abstract available.
72 results